Dirk Schürmann

Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus Infection

Florian van Bömmel, Thomas Wünsche, Stefan Mauss et al. · Hepatology · 2004 · 390 citations

A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

R. Ally, Dirk Schürmann, Wolfgang Kreisel et al. · Clinical Infectious Diseases · 2001 · 333 citations · Full text

Diagnostic Mycology, Anti-infective Agents, Antifungal Agent +13

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

Elchonon M. Berkowitz, Graeme Moyle, Hans‐Jürgen Stellbrink et al. · The Journal of Infectious Diseases · 2014 · 208 citations · Full text

SOLO

Joseph Gathe, Prudence Ive, Robin Wood et al. · AIDS · 2004 · 196 citations

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

R. Finch, Dirk Schürmann, Owen Collins et al. · Antimicrobial Agents and Chemotherapy · 2002 · 184 citations · Full text

Community-acquired Pneumonia, Oral Moxifloxacin Compared, Oral Co-amoxiclav +12